Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial

NCT05605587 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT05605587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05605587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Not applicable
Overall status
Terminated
Start date
May 2, 2023
Completion date
January 13, 2026
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

men1 gene mutation